BIZZARI JEAN-PIERRE
SEC insider (Form 3/4/5 filer). CIK 0001630914. Director at Aprea Therapeutics, Inc. (APRE) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in NEW PROVIDENCE, NJ.
Companies BIZZARI JEAN-PIERRE has filed insider reports for
- Aprea Therapeutics, Inc. (APRE): Director
- ADC Therapeutics SA (ADCT): Director
BIZZARI JEAN-PIERRE
CIK: 0001630914
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect3.1K shares- - Jun 3, 2026ADCT
ADC Therapeutics SA
Tax PaymentDirect12.6K shares at avg. $3.08$39K - Jun 1, 2026ADCT
ADC Therapeutics SA
AwardDirect45K shares- - Jun 13, 2025ADCT
ADC Therapeutics SA
Tax PaymentDirect12.6K shares at avg. $3.58$45K - Jun 5, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect1K shares- - Jun 3, 2025ADCT
ADC Therapeutics SA
AwardDirect40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  APRE Aprea Therapeutics, Inc. | Award | 3,135 | - | $0 | Direct |
| Jun 3, 2026 |  ADCT ADC Therapeutics SA | Tax Payment | 12,600 | $3.08 | $38,808 | Direct |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | Award | 45,000 | - | $0 | Direct |
| Jun 13, 2025 | ADCT ADC Therapeutics SA | Tax Payment | 12,600 | $3.58 | $45,108 | Direct |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | Award | 1,045 | - | - | Direct |
| Jun 3, 2025 | ADCT ADC Therapeutics SA | Award | 40,000 | - | - | Direct |
1-6 of 6 transactions